Thibault Mahévas

16PUBLICATIONS
43CO-AUTHORS
AllergyPharmacogenomicsAutoimmunityApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Horticultural production not elsewhere classified
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (16)

|Jul 14, 2026
Rapid efficacy of anifrolumab in refractory cutaneous dermatomyositis.

|Apr 13, 2026
Papulonodular mucinosis associated lupus erythematosus: A case series and a literature review.

William Lutz, Marie Jachiet, Jean-David Bouaziz

|Nov 10, 2025
Impact of BMI and quality of life on dupilumab response in chronic prurigo: A cohort study.

Jeanne d'Orsay, Huiyi Ke, Guillaume Mulier

|Mar 07, 2025
Efficacy and safety profile of anifrolumab in skin lesions of systemic lupus erythematosus.

Yousra Kanbar, Marie Jachiet, Chloé Grolleau

|Aug 13, 2024
Transcriptomic analysis of one patient with lupus skin lesions treated with anifrolumab.

Chloé Grolleau, Thomas Poisot, Jérôme Hadjadj

|Jul 31, 2024
Plasma cell-directed therapies induce profound clinical and durable responses in patients with severe or relapsed/refractory scleromyxedema.

F Theves, C Lahuna, T Mahévas

Pageof 3